| Dr Scot B Scheffel, MD | |
|
1188 University Dr, Boise, ID 83706 | |
| (208) 336-8250 | |
| (208) 345-9514 |
| Full Name | Dr Scot B Scheffel |
|---|---|
| Gender | Male |
| Speciality | Sports Medicine |
| Experience | 28 Years |
| Location | 1188 University Dr, Boise, Idaho |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043216823 | NPI | - | NPPES |
| 1043216823 | Medicaid | ID |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207QS0010X | Family Medicine - Sports Medicine | M7295 (Idaho) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Idaho Sports Medicine Institute, Pa | 1759278765 | 12 |
News Archive
Plan USA's "Commitment to Action" media project for girls in West Africa will be given special recognition at the 5th Annual Clinton Global Initiative (CGI) meeting on Wednesday, September 23, 2009 in New York City.
A safer method to deliver the insulin gene to diabetes patients using nanoparticles, was presented at the 10th Annual Meeting of the American Society of Gene Therapy (ASGT) in Seattle.
The human immune system uses two pre-programmed strategies to tackle infection. One is fever, a resistance mechanism that tries to eliminate a pathogen by raising the body's temperature.
The COVID-19 rapid antibody test, developed by Abingdon Health, the medical device manufacturer leading the UK-Rapid Test Consortium, has received its CE mark. This means it is approved for professional use in the UK and EU.
Below is a summary of a study published online today in Infection Control and Hospital Epidemiology. This article will be freely available for a limited time. SHEA members have full access to all ICHE articles through the online portal.
› Verified 7 days ago
| Entity Name | Idaho Sports Medicine Institute, Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1154356624 PECOS PAC ID: 1759278765 Enrollment ID: O20040303001050 |
News Archive
Plan USA's "Commitment to Action" media project for girls in West Africa will be given special recognition at the 5th Annual Clinton Global Initiative (CGI) meeting on Wednesday, September 23, 2009 in New York City.
A safer method to deliver the insulin gene to diabetes patients using nanoparticles, was presented at the 10th Annual Meeting of the American Society of Gene Therapy (ASGT) in Seattle.
The human immune system uses two pre-programmed strategies to tackle infection. One is fever, a resistance mechanism that tries to eliminate a pathogen by raising the body's temperature.
The COVID-19 rapid antibody test, developed by Abingdon Health, the medical device manufacturer leading the UK-Rapid Test Consortium, has received its CE mark. This means it is approved for professional use in the UK and EU.
Below is a summary of a study published online today in Infection Control and Hospital Epidemiology. This article will be freely available for a limited time. SHEA members have full access to all ICHE articles through the online portal.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Scot B Scheffel, MD 1188 W University Dr, Boise, ID 83706-3009 Ph: (208) 336-8250 | Dr Scot B Scheffel, MD 1188 University Dr, Boise, ID 83706 Ph: (208) 336-8250 |
News Archive
Plan USA's "Commitment to Action" media project for girls in West Africa will be given special recognition at the 5th Annual Clinton Global Initiative (CGI) meeting on Wednesday, September 23, 2009 in New York City.
A safer method to deliver the insulin gene to diabetes patients using nanoparticles, was presented at the 10th Annual Meeting of the American Society of Gene Therapy (ASGT) in Seattle.
The human immune system uses two pre-programmed strategies to tackle infection. One is fever, a resistance mechanism that tries to eliminate a pathogen by raising the body's temperature.
The COVID-19 rapid antibody test, developed by Abingdon Health, the medical device manufacturer leading the UK-Rapid Test Consortium, has received its CE mark. This means it is approved for professional use in the UK and EU.
Below is a summary of a study published online today in Infection Control and Hospital Epidemiology. This article will be freely available for a limited time. SHEA members have full access to all ICHE articles through the online portal.
› Verified 7 days ago
Dr. Maureen A Newman, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1055 N Curtis Rd, Boise, ID 83706 Phone: 208-302-5480 | |
Jessica A Evert, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1055 N Curtis Rd, Boise, ID 83706 Phone: 208-367-7350 | |
Tracy Adams, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 777 N Raymond St, Boise, ID 83704 Phone: 208-514-2500 | |
Sarah A Hershman, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 777 N Raymond St, Boise, ID 83704 Phone: 208-514-2500 Fax: 208-375-2217 | |
Summer E Szumski, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 777 N Raymond St, Boise, ID 83704 Phone: 208-514-2500 Fax: 208-375-2217 | |
Dr. Thornton E Bryan Iii, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 701 E Parkcenter Blvd, Boise, ID 83706 Phone: 208-381-6500 Fax: 208-381-6505 | |
Irvin E Sackman Jr., MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 130 E Boise Ave, Boise, ID 83706 Phone: 208-345-4066 Fax: 208-345-4196 |